|
SCC antigen levels before chemotherapy
| |
0.054
|
0.817
|
|
NACT group (n = 63)
|
38.02 (34.43, 41.61)
| | |
|
Conventional group (n = 39)
|
31.99 (29.25, 34.74)
| | |
|
NACT group
| |
0.0002
|
0.988
|
|
Chemotherapy-insensitive group (n = 32)
|
36.34 (31.50, 41.19)
| | |
|
Chemotherapy-sensitive group (n = 31)
|
38.09 (33.07, 43.12)
| | |
|
SCC antigen levels in NACT group before chemotherapy
| |
12.148
|
< 0.001
|
|
< 4.55 (n = 29)
|
NA a
| | |
|
≥ 4.55 (n = 34)
|
NA a
| | |
|
SCC antigen levels ≥4.55 before chemotherapy
| |
3.256
|
0.071
|
|
NACT group (n = 34)
|
30.21 (24.74, 35.67)
| | |
|
Conventional group (n = 22)
|
31.27 (28.21, 34.34)
| | |
|
SCC antigen levels in NACT group after the first chemotherapy
| |
13.954
|
< 0.001
|
|
< 2.70 (n = 39)
|
43.34 (41.09, 45.58)
| | |
|
≥ 2.70 (n = 24)
|
24.74 (18.80, 30.68)
| | |
